🇨🇦 Canada Country × Condition
multiple myeloma Clinical Trials in Canada
Active clinical trials for multiple myeloma with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇨🇦 Canada
Active Trials in Canada (4)
NCT05530096
Recruiting
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
Enrollment
70 pts
Country
🇨🇦 Canada
Sir Mortimer B. Davis - Jewish Gene...
View Trial → NCT05645510
Recruiting
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Enrollment
75 pts
Country
🇨🇦 Canada
University of Alberta
View Trial → NCT07555938 Phase 3
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Enrollment
380 pts
Country
🇨🇦 Canada
Hoffmann-La Roche
View Trial → NCT05372354 Phase 1, Phase 2
Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
260 pts
Country
🇨🇦 Canada
Bristol-Myers Squibb
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Canada?
There are currently 4 active clinical trials for multiple myeloma with sites in Canada, of which 4 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Canada?
To join a multiple myeloma clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Canada?
Active multiple myeloma trials in Canada span Phase 3, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology